<?xml version="1.0"?>
<template xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="openEHR/v1/Template">
  <id>7ecaad42-c212-4815-aeb9-074017108643</id>
  <name>AHS OGR PEDS CH IV Boluses</name>
  <description>
    <lifecycle_state>Initial</lifecycle_state>
    <details>
      <purpose/>
      <use/>
      <misuse/>
    </details>
    <other_details>
      <item>
        <key>MetaDataSet:Sample Set </key>
        <value>Template metadata sample set </value>
      </item>
      <item>
        <key>Acknowledgements</key>
        <value/>
      </item>
      <item>
        <key>Business Process Level</key>
        <value/>
      </item>
      <item>
        <key>Care setting</key>
        <value/>
      </item>
      <item>
        <key>Client group</key>
        <value/>
      </item>
      <item>
        <key>Clinical Record Element</key>
        <value/>
      </item>
      <item>
        <key>Copyright</key>
        <value/>
      </item>
      <item>
        <key>Issues</key>
        <value/>
      </item>
      <item>
        <key>Owner</key>
        <value/>
      </item>
      <item>
        <key>Sign off</key>
        <value/>
      </item>
      <item>
        <key>Speciality</key>
        <value/>
      </item>
      <item>
        <key>User roles</key>
        <value/>
      </item>
    </other_details>
  </description>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]">
    <items>
      <item>
        <key>Technical.ﻩ Technical Traceability</key>
        <value>{~AHSID~7ecaad42-c212-4815-aeb9-074017108643~NAME~AHS OGR PEDS CH IV Boluses}</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.clinical_guidance.v1]">
    <items>
      <item>
        <key>CKT.Clinical Guidance</key>
        <value>&lt;p&gt;Sodium Chloride 0.9% is the preferred bolus solution for most hospitalized patients. &amp;nbsp;However when large volumes are required this can result in hyperchloremia with negative consequences particularly kidney injury. Use of Plasmalyte or Ringer’s Lactate should be considered when boluses are required and in particular when bolus volumes exceed 20 mL/kg, if chloride is greater than 110 mmol/L, if there is metabolic acidosis (HCO3 less than 22 mmol/L) or if creatinine is elevated above the normal range (or 1.3X the patients baseline value).&lt;/p&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1]">
    <items>
      <item>
        <key>Transform.Clinical Notes</key>
        <value>&lt;p&gt;Technical Note: &amp;nbsp;Nested panel is collapsed by default&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-INSTRUCTION.section_supporting_context.v1]">
    <items>
      <item>
        <key>Transform.Preselected</key>
        <value>&lt;p&gt;N&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <definition xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" name="IV Boluses">
    <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" path="/items"/>
    <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="4ad170dc-0168-4a5e-b18d-b84496da37b8" concept_name="PHARM sodium chloride 0.9% bolus order" max="1" path="/items" name="sodium chloride 0.9 % bolus; *** mL/kg/dose, intravenous, once, As fast as possible"/>
    <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="33c120d1-58b1-4cf7-bd5e-f81fad5849b8" concept_name="PHARM electrolyte solution (Plasma-Lyte A) injection Order" max="1" path="/items" name="electrolyte solution (PLASMA-LYTE A) bag; *** mL/kg/dose, intravenous, once, As fast as possible"/>
    <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="295a233b-429a-4871-864a-37589a4d16ee" concept_name="PHARM lactated Ringer_s infusion Order" max="1" path="/items" name="lactated Ringer&apos;s infusion; *** mL/kg/dose, intravenous, once, As fast as possible"/>
    <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="Dextrose bolus - ONLY FOR SYMPTOMATIC HYPOGLYCEMIA IF ORAL THERAPY CANNOT BE USED">
      <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.section_supporting_context.v1" concept_name="Section supporting context" path="/items"/>
      <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="38385979-e2ab-4d77-aed7-a1b51519a42d" concept_name="PHARM dextrose 10% in water infusion Order" max="1" path="/items" name="D10W infusion bag; 2.5 mL/kg/dose IV once STAT, As fast as possible"/>
    </Item>
  </definition>
  <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-SECTION.adhoc.v1">
    <digest id="MD5-CAM-1.0.1">8AE70853975A75254E6D39A8DE3652AF</digest>
  </integrity_checks>
  <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1">
    <digest id="MD5-CAM-1.0.1">4B2F0F6CD593E442DA9C30277A3EA9CF</digest>
  </integrity_checks>
  <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1">
    <digest id="MD5-CAM-1.0.1">AD8DFB192E67715F0D9E11E95E674AD0</digest>
  </integrity_checks>
  <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-CLUSTER.service_request_information.v1">
    <digest id="MD5-CAM-1.0.1">230A8D964017E1FD7AC82EBDEE0202A6</digest>
  </integrity_checks>
  <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-INSTRUCTION.section_supporting_context.v1">
    <digest id="MD5-CAM-1.0.1">A7EC4E4C870D8C3431B29F6514353416</digest>
  </integrity_checks>
</template>